w2.cytomed.sg (GDTC) - Cash on Hand per Share

Symbol and logo of brand CytoMed Therapeutics Limited (GDTC)

CytoMed Therapeutics (GDTC) relies on the high scalability of cell technologies to capture the global market. Proprietary patents for gamma-delta T-cells and lobbying efforts in Asia create significant barriers to entry for competitors, as confirmed by the cash per share distribution on GURU.Markets. The current 0.10 represents a fresh level value, while the lack of profit at the preclinical stage leaves the company dependent on existing reserves.

w2.cytomed.sg - GDTC Cash per Single Share (period 02/21/2024 - 11/20/2026)

Comprehensive metric breakdowns and analytics for w2.cytomed.sg (GDTC)

- stock value and consensus price forecast:
- cash and cash flow data:
Summary company analysis:GDTC (CytoMed Therapeutics Ltd)
Finished products of CytoMed Therapeutics

Monitoring liquid asset volume is critical for assessing the financial stability of CytoMed Therapeutics (GDTC). This metric determines the amount of cash available per common share. By analyzing the current cash per share, an investor can gauge the company's ability to fund R&D without relying on external loans. For a biotech firm developing universal NK-therapy, this serves as a guarantee of development autonomy. Sufficient liquidity confirms the viability of the expansion strategy within the global cell medicine market.

Analysis of competing companies

Cash Funds per Single Share ONC (BeiGene Corp)|Cash per Single Share HALO (Halozyme Therapeutics, Inc.)|Cash per Share Revolution Medicines, Inc. (RVMD)|Cash per Share AAPG (ascentage.com)|CG Oncology Inc (CGON) - Cash on Hand per Share|URGN - Cash Funds per Share|Bicara Bio - Cash Calculated per Single Share|PSNL: Cash per Share|Cash Funds per Single Share ERAS|Cash per Single Share DCTH|Cash on Hand per Share Y-mAbs Therapeutics Inc YMAB|Cash per Share AURA|CADL (Candel Therapeutics, Inc.) - Amount of Cash per Share|Cash Funds per Share Accuray Inc ARAY|Cash Funds Calculated per Share SELLAS Life Sciences Group Inc. (SLS)|actuatetherapeutics.com - Cash per Share|Cash on Hand per Share Citius Oncology|HURA: Cash per Share|Cash Money per Share TARA (Protara)|FATE (fatetherapeutics.com) - Cash per Share|Cash on Hand per Share Aadi Bioscience WHWK|Cash per Share TCRX|CSBR - Cash on Hand per Share|XBiotech - Cash per Single Share|CEL-SCI Corporation (CVM) - Cash on Hand per Share|OSTX - Cash Funds per Share|Cash on Hand per Share Radiopharm Theranostics Ltd|ARTV (artivabio.com) - Cash per Single Share|ANL (Adlai Nortye Ltd) - Cash Funds per Share|Cash per Single Share VERU|Tempest Therapeutics (TPST) - Cash Funds Calculated per Share|Cash per Share XLO|Cash per Single Share Renovaro RENB|Cash per Share MURA (Mural Oncology PLC)|KAPA - Cash per Single Share|OnKure Therapeutics - Cash per Share|CRIS - Cash per Share|APLM: Cash per Share|Cash on Hand per Share tharimmune.com (THAR)|ADVB (Advanced Biomed Corp) - Cash per Share|Cash per Share Genprex Inc.|Cash per Share CLDI|Cash per Single Share Sunshine Biopharma, Inc. SBFM|Cash per Share XBIO (Xenetic Biosciences)|Amount of Cash per Share SLRX|PPBT - Cash Funds per Share|AONC (aoncology.com) - Cash Funds per Single Share|BGNE: Cash per Share|Checkpoint Therapeutics Inc (CKPT) - Cash per Share|ELEV (Elevation Oncology Inc.) - Cash per Share|icadmed.com (ICAD) - Cash Funds Calculated per Share|Cash per Share IKNA|NTBL (Notable Labs) - Amount of Cash per Share|Cash per Share VIRX (Viracta Therapeutics)|Cash Funds Calculated per Share MorphoSys AG (MOR)|NAYA Biosciences Corp - Cash per Share|Cash on Hand per Share ascentage.com